Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02111681 · ClinicalTrials.gov registry record · NA
Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments of Lung Cancer
A NA study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT02111681: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02111681 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02111681, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to test the use of Calypso beacon implants as a way to determine where the lung tumor is located during radiation treatment. The Calypso beacons are small devices that are implanted in the lungs, near the tumor. They are able to send a signal to a tracking system to show where they are, and where the tumor is, as the patient holds their breath for the radiation treatment. The investigators want to find out what effects, good and/or bad, that this has on the patient and the way they treat the cancer in your lungs.
Interventions
- DEVICE Calypso Beacon Implantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2014-04 |
| Est. Completion | 2024-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02111681
The ClinicalTrials.gov registry entry for NCT02111681 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Calypso Beacon Implantation is the first listed.
NCT02111681 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02111681 about?
NCT02111681 is a clinical study titled "Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments of Lung Cancer". The purpose of this study is to test the use of Calypso beacon implants as a way to determine where the lung tumor is located during radiation treatment. The Calypso beacons are small devices that are implanted in the lungs, near the tumor. They are able to send a signal to a tracking system to show...
What is the current status of trial NCT02111681?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2014-04. Estimated completion is 2024-07-01.
What interventions are being tested in trial NCT02111681?
The interventions under investigation include: Calypso Beacon Implantation (DEVICE).
Who is sponsoring clinical trial NCT02111681?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.